Article

Iridex shows its latest infrared photocoagulator

Iridex presented its IRIS Medical IQ 810, a state-of-the-art infrared photocoagulator, to attendees at the European Society of Cataract and Refractive Surgeons meeting.

Paris—Iridex presented its IRIS Medical IQ 810, a state-of-the-art infrared photocoagulator, to attendees at the European Society of Cataract and Refractive Surgeons meeting.

Designed to perform traditional and the company's Minimum Intensity Photocoagulation (MIP) procedures, the infrared diode laser features SmartWave interactive software for intuitive set up and operation, customized laser output, and settings and integrated system diagnostics. SmartWave also enables quick access to the unit's CW-Pulse (continuous-wave), MicroPulse, and LongPulse operation modes.

The IQ 810 offers graphic user interface, permitting treatment settings to be reviewed, programmed, and monitored quickly and easily. The display features a wide angle of view and sharp contrast that provides clear visibility under a range of light conditions. Lightweight and portable, the unit is compatible with a variety of delivery devices made by Iridex.

The IQ 810 is not for sale in the United States.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.